Brian Piekos Insider Profile
11 Followers
Brian Piekos, Chief Financial Officer at Amag Pharmaceuticals, holds 18.15K shares in KalVista Pharmaceuticals (Ticker: KALV), holds 17.61K shares in Disc Medicine (Ticker: IRON), holds 0.00 shares in Amag Pharmaceuticals (Ticker: AMAG).
Brian Piekos Amag Pharmaceuticals (AMAG)Chief Financial Officer
Amag Pharmaceuticals (AMAG)
Chief Financial Officer
Not Ranked
Brian Piekos has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Piekos holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brian Piekos
Brian Piekos's Trading History
Amag Pharmaceuticals
Nov 17, 2020
―
Uninformative Sell
―
$0.00
Disc Medicine
Jun 02, 2022
CFO
Uninformative Buy
10.86K
$1.18M
Elicio Therapeutics
―
CFO
―
―
KalVista Pharmaceuticals
Apr 20, 2026
CFO
Uninformative Buy
85.83K
$483.70K
List of latest transactions for each holding click on a transaction to see Brian Piekos's performance on stock
You May Also Like
Brian Piekos insider profile FAQ
What is the percentage of profitable transactions made by Brian Piekos?
The percentage of profitable transactions made by Brian Piekos is ―.
What is the average return per transaction made by Brian Piekos?
The average return per transaction made by Brian Piekos is ―.
What stocks does Brian Piekos hold?
Brian Piekos holds: AMAG, IRON, ELTX, KALV stocks.
What was Brian Piekos’s latest transaction?
Brian Piekos latest transaction was an Uninformative Buy of $85.83K.
What was Brian Piekos's most profitable transaction?
Brian Piekos’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brian Piekos's role in Amag Pharmaceuticals?
Brian Piekos's role in Amag Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.